{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-014835","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.440838+00:00","generated_at":"2026-05-15T07:50:09.565511+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Lipocine updates corporate presentation; no material new details disclosed in filing","bullets":["Company filed an 8-K on April 2, 2026, stating it updated its corporate presentation used with investors.","Presentation filed as Exhibit 99.1 but no specific content or changes were described in the filing text.","No financial or operational metrics, guidance, or business developments were reported.","Filing appears routine and lacks substantive information for investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-014835","json":"https://secwatch.observer/filing/0001493152-26-014835.json","markdown":"https://secwatch.observer/filing/0001493152-26-014835.md","text":"https://secwatch.observer/filing/0001493152-26-014835.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226014835/0001493152-26-014835-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226014835/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:50:09.565511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}